[Cancer of the ovary. Comparative value of serum CA-125, immunochemistry and biological tests of inflammation].
The marker CA-125 is not specific of malignant ovarian tumors but, when its titration is positive, its evolution permits to follow correctly the development of the tumor. The authors report their experience with 180 titrations coupled with the titration of inflammation markers.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000097:blood*; D015295:Antigens, Tumor-Associated, Carbohydrate; D003131:Combined Modality Therapy; D005260:Female; D006242:Haptoglobins / Q000032:analysis; D006801:Humans; D007124:Immunoenzyme Techniques; D008875:Middle Aged; D009961:Orosomucoid / Q000032:analysis; D010051:Ovarian Neoplasms / Q000097:blood* / Q000276:immunology / Q000628:therapy; D011228:Prealbumin / Q000032:analysis
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D006242:Haptoglobins; D009961:Orosomucoid; D011228:Prealbumin
Cancer de l'ovaire. Intérêt comparé du Ca-125 sérique de l'immunohistochimie et des tests biologiques de l'inflammation.